How the National Academy of Inventors Recognizes AI Healthcare Inventors

The keyword points to the National Academy of Inventors, not the National Academy of Medicine, though NAM remains a useful neighboring signal of broader scientific standing. That distinction matters here, because the useful question is not which institution sounds grander, but which one turns AI-heavy academic invention into a credential that can actually travel through disclosure, patenting, and licensing.

NAI does that through two distinct tiers: Fellows and Senior Members. The split is useful because it separates a mature inventing record from the earlier-career record that is still building toward it, which is exactly how a technology-transfer office tends to read a promotion ladder.

Two tiers, two signals

The election structure is the part that keeps this from looking like ceremonial branding. Both programs are election-based recognitions, so the signal is not just that someone made something interesting; it is that the institution and the academy have already tested that record against a real selection process [1][3].

Why the credential matters

For academic AI healthcare inventors, the point is not prestige for its own sake. NAI Fellows collectively sit on an enormous patent base, and the organization says those inventions have generated an estimated $3.8 trillion in revenue and 1.4 million jobs [1]. That makes the academy's recognition more like an institutional shorthand for whether a lab result has already become protectable, licensable, and relevant to the translation pipeline.

The overlap with the broader scientific establishment is also real: more than 796 NAI Fellows are also members of the National Academies of Science, Engineering, and Medicine [1]. That does not collapse inventor recognition into academic celebrity, but it does show that NAI sits on the same map as the country's other high-status scientific bodies.

What the 2025-2026 cohorts say about AI

The 2025 Fellow class is a good snapshot of how AI now appears inside the inventor pipeline rather than beside it. NAI elected 169 U.S. Fellows from 127 institutions across 40 states, and the class was framed around AI, quantum computing, and regenerative medicine rather than around one isolated technical theme [2]. That mix matters because AI healthcare invention rarely lives as pure software; it usually shows up where algorithms meet imaging, devices, workflow, or patient-facing systems.

The 2026 Senior Member class pushes the same story one rung earlier. NAI named 230 emerging inventors from 82 institutions, the largest class to date, and those members collectively hold more than 2,000 U.S. patents [4]. For universities, that is the more interesting signal: the academy is not waiting until AI healthcare inventors are fully established before it starts treating them as part of the formal inventing class.

The named inventors make the pattern concrete

Jianming Liang at Arizona State University is the clearest example of what this looks like in practice. He is an NAI Fellow with 33 U.S. patents tied to AI and deep learning for computer-aided diagnosis, which is exactly the sort of portfolio that can move from a lab notebook into a licensing conversation because it is already anchored to a clinical use case [6].

Krishnendu Chakrabarty at Duke shows that the category is broader than image analysis alone. His NAI Fellow profile sits at the intersection of AI for healthcare and microfluidic biochips, which is a reminder that medical invention often depends on the hardware and process layer as much as on the model layer [2].

Steven H. Liang at Emory University belongs to the newer side of the ladder. Emory identified him as a 2026 NAI Senior Member for work on AI-enabled radiopharmaceutical development, a good example of how the program now reaches into fields where computational methods and clinical chemistry are becoming harder to separate [4][7].

NAI has also started to address AI inventorship directly. Its guidance on AI and inventorship is aimed at incentivizing human ingenuity and investment in AI-assisted inventions, which is a more useful institutional stance than either boosterism or blanket caution [5].

That is why the current cohorts matter more than any single headline. They suggest that AI is becoming a normal part of how academic biomedical invention is sorted, promoted, and recognized. For people working in university tech transfer, NAI recognition now looks less like a peripheral accolade and more like a visible credential in the path from disclosure to licensing meeting to clinical adoption.

References

1. About the NAI Fellows Program — National Academy of Inventors — https://academyofinventors.org/about-the-nai-fellows-program/
2. NAI Welcomes 2025 Class of Fellows — National Academy of Inventors — https://academyofinventors.org/nai-welcomes-2025-class-of-fellows/
3. About the Senior Members Program — National Academy of Inventors — https://academyofinventors.org/about-the-senior-members-program/
4. NAI Welcomes Newest Class of Senior Members — National Academy of Inventors — https://academyofinventors.org/nai-welcomes-newest-class-of-senior-members/
5. AI and Inventorship Guidance: Incentivizing Human Ingenuity and Investment in AI-assisted Inventions — National Academy of Inventors — https://academyofinventors.org/publications/ai-and-inventorship-guidance-incentivizing-human-ingenuity-and-investment-in-ai-assisted-inventions/
6. ASU researcher named Fellow of National Academy of Inventors — Arizona State University — 2021-12-07 — https://news.asu.edu/20211207-asu-researcher-named-fellow-national-academy-inventors
7. National Academy of Inventors honors Steven H. Liang as a 2026 Senior Member — Emory University — 2026-06 — https://news.emory.edu/stories/2026/06/national-academy-inventors-honors-steven-h-liang-2026-senior-member